Sodium oxymethylene

British scientist James W. Black developed propranolol in the 1960s. [64] In 1988, he was awarded the Nobel Prize in Medicine for this discovery. Propranolol was inspired by the early β-adrenergic antagonists dichloroisoprenaline and pronethalol . The key difference, which was carried through to essentially all subsequent beta blockers, was the inclusion of an oxymethylene group (-O-CH 2 -) between the aryl and ethanolamine moieties of pronethalol, greatly increasing the potency of the compound. This also apparently eliminated the carcinogenicity found with pronethalol in animal models.

Sodium oxymethylene

sodium oxymethylene

Media:

sodium oxymethylenesodium oxymethylenesodium oxymethylenesodium oxymethylenesodium oxymethylene